第一单位:
Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
作者:
Eriko,Komiya [1]
;
Ryo,Hatano [2]
;
Haruna,Otsuka [2]
;
Takumi,Itoh [3]
;
Hiroto,Yamazaki [2]
;
Taketo,Yamada [4]
;
Nam H,Dang [5]
;
Mitsutoshi,Tominaga [6]
;
Yasushi,Suga [7]
;
Utako,Kimura [7]
;
Kenji,Takamori [8]
;
Chikao,Morimoto [2]
;
Kei,Ohnuma [9]
作者单位:
Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
[1]
Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
[2]
Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Graduate School of Health and Sports Science, Juntendo University, 1-1 Hiragagakuendai, Inzai, Chiba 270-1695, Japan.
[3]
Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Pathology Saitama Medical University, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0459, Japan.
[4]
Division of Hematology/Oncology, University of Florida, 1600 SW Archer Road- Box 100278, Room MSB M410A, Gainesville, FL 32610, USA.
[5]
Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
[6]
Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
[7]
Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan; Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
[8]
Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Electronic address: kohnuma@juntendo.ac.jp.
[9]
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);动物(Animals);止痒药(Antipruritics);行为, 动物(Behavior, Animal);病例对照研究(Case-Control Studies);二肽基肽酶4(Dipeptidyl Peptidase 4);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);人类(Humans);男(雄)性(Male);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);中年人(Middle Aged);表型(Phenotype);瘙痒症(Pruritus);银屑病(Psoriasis);P物质(Substance P);时间因素(Time Factors);增量调节(Up-Regulation);青年人(Young Adult)
DOI
10.1016/j.jdermsci.2017.03.005
PMID
28365081
发布时间
2018-03-06